ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Avenue Therapeutics Inc

Avenue Therapeutics Inc (ATXI)

1.975
-0.035
( -1.74% )
更新日時: 00:24:39

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
1.975
買値
1.93
売値
2.03
出来高
2,827
1.95 日の範囲 2.038
1.60 52 週間の範囲 26.4675
時価総額
前日終値
2.01
始値
1.95
最終取引時間
00:33:03
財務取引量
US$ 5,573
VWAP
1.9715
平均取引量 (3 か月)
45,910
発行済株式数
1,431,356
配当利回り
-
PER
-0.28
1 株当たり利益 (EPS)
-7.25
歳入
-
純利益
-10.38M

Avenue Therapeutics Inc について

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Dover, Delaware, USA
設立
-
Avenue Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ATXI. The last closing price for Avenue Therapeutics was US$2.01. Over the last year, Avenue Therapeutics shares have traded in a share price range of US$ 1.60 to US$ 26.4675.

Avenue Therapeutics currently has 1,431,356 shares in issue. The market capitalisation of Avenue Therapeutics is US$2.88 million. Avenue Therapeutics has a price to earnings ratio (PE ratio) of -0.28.

ATXI 最新ニュース

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

Avenue Therapeutics to Participate in Upcoming Investor Conferences

MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.0251.282051282051.952.061.6346051.93626125CS
4-0.165-7.710280373832.142.631.6516082.23095262CS
12-0.5551-21.93984427492.53013.541.6459102.24038054CS
26-1.895-48.96640826873.873.98991.6444472.70191159CS
52-13.1-86.898839137615.07526.46751.6197359517.11888208CS
156-1393.025-99.858422939113952013.751.61797302341.8651411CS
260-6421.775-99.96925471886423.75141301.61146781710.49741879CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
WORXSCWorx Corporation
US$ 1.94
(97.96%)
99.02M
CRNCCerence Inc
US$ 5.30
(87.94%)
23.7M
SKKSKK Holdings Limited
US$ 7.32
(60.53%)
5.65M
IBGInnovation Beverage Group Limited
US$ 1.26
(59.25%)
4.2M
SURGSurgePays Inc
US$ 2.115
(44.86%)
11.62M
PYXSPyxis Oncology Inc
US$ 2.08
(-45.55%)
8.22M
KURAKura Oncology Inc
US$ 9.9613
(-37.39%)
6.84M
SHOTWSafety Shot Inc
US$ 0.1001
(-33.27%)
2.5k
BLRXBioLineRx Ltd
US$ 0.37
(-32.13%)
4.96M
TMTCTMT Acquisition Corporation
US$ 4.66
(-27.64%)
12.11k
CDTConduit Pharmaceuticals Inc
US$ 0.1156
(25.24%)
463.61M
NVDANVIDIA Corporation
US$ 143.17
(-1.86%)
180.58M
AKTSAkoustis Technologies Inc
US$ 0.1049
(20.44%)
177.49M
ELABElevai Labs Inc
US$ 0.0203
(-5.14%)
115.33M
WORXSCWorx Corporation
US$ 1.9353
(97.48%)
99.94M

ATXI Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock